Response to First-Line Osimertinib Treatment in Non-Small-Cell Lung Cancer With Coexisting G719A and Primary T790M Epidermal Growth Factor Receptor Mutations

被引：1
|
作者：
Ikari, Tomoo [1 ]
Sakakibara-Konishi, Jun [1 ]
Yamamoto, Gaku [1 ]
Kitai, Hidenori [1 ]
Mizugaki, Hidenori [1 ]
Asahina, Hajime [1 ]
Kikuchi, Eiki [1 ]
Shinagawa, Naofumi [1 ]
机构：
[1] Hokkaido Univ Hosp, Dept Med 1, Sapporo, Hokkaido, Japan
来源：
CLINICAL LUNG CANCER | 2019年 / 20卷 / 04期
关键词：
Compound mutation; EGFR mutation; EGFR-TKI; Lung adenocarcinoma; Uncommon mutation; EGFR MUTATION; CHEMOTHERAPY; AFATINIB;
D O I：
10.1016/j.cllc.2019.05.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E531 / E533
页数：3
相关论文
共 50 条
  • [1] First-line osimertinib treatment in a patient with lung adenocarcinoma with coexisting epidermal growth factor receptor G719S and de novo T790M mutations
    Ito, Noriaki
    Masuda, Takeshi
    Ooka, Ikuko
    Hosoya, Takatsune
    Yamaguchi, Kakuhiro
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Nakashima, Taku
    Miyamoto, Shintaro
    Iwamoto, Hiroshi
    Fujitaka, Kazunori
    Hamada, Hironobu
    Hattori, Noboru
    [J]. THORACIC CANCER, 2022, 13 (05) : 771 - 774
  • [2] First-line osimertinib in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met
    Majem, Margarita
    Sullivan, Ivanna
    Viteri, Santiago
    Lopez-Vivanco, Guillermo
    Cobo, Manuel
    Sanchez, Jose M.
    Garcia-Gonzalez, Jorge
    Garde, Javier
    Sampayo, Miguel
    Martrat, Griselda
    Malfettone, Andrea
    Karachaliou, Niki
    Molina-Vila, Miguel A.
    Rosell, Rafael
    [J]. EUROPEAN JOURNAL OF CANCER, 2021, 159 : 174 - 181
  • [3] High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancer
    Ariyasu, Ryo
    Nishikawa, Shingo
    Uchibori, Ken
    Oh-hara, Tomoko
    Yoshizawa, Takahiro
    Dotsu, Yosuke
    Koyama, Junji
    Saiki, Masafumi
    Sonoda, Tomoaki
    Kitazono, Satoru
    Yanagitani, Noriko
    Horiike, Atsushi
    Inase, Naohiko
    Kasahara, Kazuo
    Nishio, Makoto
    Katayama, Ryohei
    [J]. LUNG CANCER, 2018, 117 : 1 - 6
  • [4] Life-threatening pneumonitis after first-line treatment with osimertinib for primary T790M mutated non-small cell lung cancer
    Haentschel, Maik
    Niebling, Johannes
    Haering, Almut
    Haering, Max-Felix
    Gross, Thorben
    Horger, Marius
    Riessen, Reimer
    Haap, Michael
    Lewis, Richard A.
    Boeckeler, Michael
    Hetzel, Juergen
    [J]. THORACIC CANCER, 2020, 11 (07) : 2044 - 2047
  • [5] Epidermal growth factor receptor T790M mutation-positive metastatic non-small-cell lung cancer: focus on osimertinib (AZD9291)
    Saad, Nibal
    Poudel, Aarati
    Basnet, Alina
    Gajra, Ajeet
    [J]. ONCOTARGETS AND THERAPY, 2017, 10 : 1757 - 1765
  • [6] High sensitivity detection of epidermal growth factor receptor (EGFR) T790M mutants in non-small-cell lung cancer
    Tracey, J.
    Clark, C.
    Bell, C.
    Kerr, K. M.
    Nicolson, M.
    Miedzybrodzka, Z.
    Kelly, K.
    [J]. LUNG CANCER, 2013, 79 : S7 - S8
  • [7] Management of non-small cell lung cancer harboring epidermal growth factor receptor mutations in the era of first-line osimertinib
    Hakozaki, Taiki
    Okuma, Yusuke
    [J]. JOURNAL OF THORACIC DISEASE, 2019, 11 (07) : 2664 - 2668
  • [8] Epidermal growth factor receptor T790M mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
    Yongchun Zhou
    Yuhui Ma
    Hutao Shi
    Yaxi Du
    Yunchao Huang
    [J]. Scientific Reports, 8
  • [9] Epidermal growth factor receptor T790M mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
    Zhou, Yongchun
    Ma, Yuhui
    Shi, Hutao
    Du, Yaxi
    Huang, Yunchao
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [10] Best practices in epidermal growth factor receptor T790M testing for advanced non-small-cell lung cancer in Hong Kong
    Nyaw, Jonathan S. F.
    Cheung, K. M.
    Hioe, F.
    Kam, Michael T. Y.
    Lau, Johnny K. S.
    Lau, Y. M.
    Leung, Dennis K. C.
    Lim, Fiona M. Y.
    [J]. HONG KONG MEDICAL JOURNAL, 2023, 29 (03) : 240 - 246
12345